0001140361-14-012242.txt : 20140311 0001140361-14-012242.hdr.sgml : 20140311 20140311190649 ACCESSION NUMBER: 0001140361-14-012242 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20140307 FILED AS OF DATE: 20140311 DATE AS OF CHANGE: 20140311 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HANGER, INC. CENTRAL INDEX KEY: 0000722723 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-SPECIALTY OUTPATIENT FACILITIES, NEC [8093] IRS NUMBER: 840904275 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10910 DOMAIN DRIVE STREET 2: SUITE 300 CITY: AUSTIN STATE: TX ZIP: 78758 BUSINESS PHONE: 512-777-3800 MAIL ADDRESS: STREET 1: 10910 DOMAIN DRIVE STREET 2: SUITE 300 CITY: AUSTIN STATE: TX ZIP: 78758 FORMER COMPANY: FORMER CONFORMED NAME: HANGER ORTHOPEDIC GROUP INC DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: SEQUEL CORP DATE OF NAME CHANGE: 19890814 FORMER COMPANY: FORMER CONFORMED NAME: CELLTECH COMMUNICATIONS INC DATE OF NAME CHANGE: 19860304 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Wilson Kenneth W. CENTRAL INDEX KEY: 0001530777 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-10670 FILM NUMBER: 14685735 MAIL ADDRESS: STREET 1: C/O HANGER ORTHOPEDIC GROUP, INC. STREET 2: 10910 DOMAIN DRIVE, SUITE 300 CITY: AUSTIN STATE: TX ZIP: 78758 4 1 doc1.xml FORM 4 X0306 4 2014-03-07 0 0000722723 HANGER, INC. HGR 0001530777 Wilson Kenneth W. C/O HANGER ORTHOPEDIC GROUP, INC. 10910 DOMAIN DRIVE, SUITE 300 AUSTIN TX 78758 0 1 0 0 Pres./COO Southern Prosthetic* Common Stock 2014-03-07 4 A 0 3661 0 A 29586 D Common Stock 2014-03-11 4 S 0 1090 35.8843 D 28496 D Represents a grant of time-based restricted stock under the Company's 2010 Omnibus Incentive Plan (the "Plan"), which vests to the extent of 25% annually on the first anniversary date of the grant and cumulatively vests to the extent of 25% each year thereafter. The restricted stock being reported does not include the contingent right of the reporting person to receive up to 3,662 additional performance shares under the Plan based on the achievement of certain performance targets for the fiscal year 2014. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. The shares of common stock were sold to cover taxes incurred as a result of the vesting of restricted shares. Includes (i) unvested restricted shares totaling 3,661 shares of stock from an initial grant of 3,661 shares of restricted stock made on March 7, 2014; (ii) unvested restricted shares and fully vested shares totaling 6,985 shares of stock from an initial grant of 8,075 shares of restricted stock and performance shares made on March 11, 2013; (iii) unvested restricted shares and fully vested shares which total 10,350 shares of stock from an initial grant of 13,800 shares of restricted stock and performance shares made on March 7, 2012; and (iv) unvested restricted shares totaling 7,500 shares of stock from an initial grant of 15,000 shares of restricted stock made on September 19, 2011. All remaining unvested restricted shares will continue to vest at a rate of 25% per year of the original grant amount on the anniversary date of the grant. * President and Chief Operating Officer of Southern Prosthetic Supply, Inc. /s/ Jessica Lochmann Allen, Attorney-in-Fact for Kenneth W. Wilson 2014-03-11